Video-native documentation layer for GI ASC operators that turns endoscopy footage into signed notes and payer-defensible CPT evidence.

1. Surgeons still writing operative notes from memory means the documentation bottleneck is current and expensive, not a solved back-office task.
2. Computer vision can now map procedural steps and coding cues directly from video, which changes video from archive footage into structured claim input.
3. Live deployments plus a 400 room pipeline show providers are willing to operationalize this workflow at enterprise scale rather than keep it in pilot limbo.
4. Venture funding behind a system of record for surgery indicates documentation and reimbursement are credible entry points to a much larger surgical data platform.

Catalyst. Same-day reports of live deployments, real-time video-to-note generation, and a 400-room pipeline show that surgical video has crossed from archive media into structured workflow input, making reimbursement automation newly credible.

The product ingests procedure video, scope metadata, room timestamps, and existing documentation templates to produce a draft note immediately after the case instead of hours later. It highlights detected procedural steps, likely CPT support points, and any missing evidence so the surgeon and coder review one structured draft rather than starting from scratch. Every generated statement links back to a timestamped clip or event marker, creating an audit trail that can be used for internal QA, coder handoff, and payer defense. The first release stays narrowly focused on endoscopy because the video is already available, the workflows are repetitive, and same-day documentation quality directly affects throughput and reimbursement.

What's different. Most ambient-clinical AI starts from speech or typed text and produces a summary that still lacks hard evidence when a coder or payer questions the case. This company starts from the primary source of truth in endoscopy and surgery, then turns each documentation claim into a timestamped evidence trail that can survive compliance review. Defensibility grows as the system learns specialty-specific procedure ontologies, surgeon edit patterns, and which evidence packets most reliably clear coding review and audit challenges.

Jobs to be done

flowchart LR
  Buyer[ASC revenue cycle lead] --> Pain[Memory-based notes and downcoded claims]
  Pain --> Product[Video-native procedure note engine]
  Product --> Outcome[Faster signed notes and cleaner reimbursement]

Executive takeaways

• GI and endoscopy are a credible first wedge because the raw evidence source already exists on video, procedure steps are repetitive, and quality indicators already demand structured documentation such as cecal photo proof, bowel prep quality, and EGD photodocumentation.
• Buyer urgency is economic rather than aspirational: denials, documentation gaps, staffing pressure, and room-throughput sensitivity make same-day, evidence-linked reporting easier to budget than speculative clinical AI.
• No incumbent wins by default. Template reporting suites own workflow, ambient AI owns speech-first documentation, and surgical-intelligence vendors own video analytics, but none clearly owns GI-specific, reimbursement-defensible video-to-note automation.
• The best beachhead is the multi-site GI MSO or PE-backed ASC platform because it concentrates procedures, coding teams, integration work, and post-acquisition standardization pressure into a small number of accounts.

Market definition

U.S. software and workflow infrastructure for endoscopy procedure documentation, coding support, and audit-defensible evidence capture, focused on colonoscopy and upper-GI workflows in multi-site ambulatory surgery and endoscopy operators. The wedge is narrower than general ambient AI or perioperative intelligence: it is the conversion of procedure video plus room metadata into a surgeon-reviewed note and coding evidence packet before the claim workflow advances.

Customer and buyer

Primary users are endoscopy operations leaders, GI medical directors, and centralized coding managers who need same-day signed notes and defensible procedure evidence. The economic buyer is typically the CFO or VP of revenue cycle at a PE-backed or multi-site GI platform, because the pain shows up in denials, delayed cash, coder backlog, and inconsistent post-acquisition documentation standards.

Buying triggers

• Documentation gaps, coding disputes, and rising denial-management cost make better evidence capture an immediate revenue-cycle priority. [6][7][8]
• High-volume GI centers live or die on room efficiency, rapid turnover, and same-day paperwork discipline, so delayed notes or late-start cascades quickly become throughput problems. [9][39]
• Multi-site GI platforms standardizing across acquired centers already buy documentation platforms and seek cloud-first operating models, which creates a budget line for workflow modernization. [19][20][22][23]
• CMS and society quality programs keep pushing measurement and public reporting deeper into ASC and endoscopy workflows, raising the cost of weak documentation hygiene. [10][11][18][37]

Willingness to pay

Budget justification is strongest when sold against denial rework, manual documentation time, coder backlog, and room-throughput disruption rather than abstract AI value. Providers already lose meaningful dollars to denials, add staff to fight them, and buy specialized GI documentation systems today, so a video-native layer can win if it measurably shortens note turnaround and reduces audit friction. [6][7][8][9][23][24]

Category dynamics

Growth signal +5.7% 2023 ASC surgical procedures per FFS beneficiary

Validation signals

• Uncovr's funding round and stated deployment pipeline show investors and providers now view video-to-note workflow as commercially credible.
• United Digestive's standardization on Provation Apex confirms that large GI operators already buy platform-wide documentation modernization.
• University of Miami's live AI surgical agent cut median signed-note time from about 26 minutes to under two minutes, proving the time-savings claim is technically plausible.

Regulatory & technical constraints

• Operative documentation remains a regulated clinical record that must be written immediately after surgery and signed by the surgeon, so AI output has to fit a human-reviewed workflow.
• Colonoscopy and EGD reporting must meet explicit quality benchmarks including cecal landmark photo proof, bowel prep documentation, and EGD photodocumentation.
• ASC quality data are collected and publicly reported through CMS programs, which raises expectations for auditable data quality.
• Covered entities must perform ongoing risk analysis across all systems that store or access ePHI, not just the EHR, which directly affects medical-video architectures.

Competition comes from four directions: incumbent GI reporting suites, ambient clinical documentation platforms, surgical-video intelligence vendors, and the entrenched substitute of surgeon dictation plus coder review inside existing EHR/reporting stacks. The white space is not generic note generation; it is a GI-specific workflow that can tie each coded claim element back to timestamped video evidence.

Why incumbents do not win by default

• Endoscopy reporting suites. They own templates, images, and installed GI workflow, but they generally start from manual entry rather than converting video into auditable evidence automatically.
• Ambient documentation platforms. They reduce typing and support coding, but their center of gravity is speech- and chart-derived summarization rather than video-native proof of what happened during the procedure.
• Surgical intelligence platforms. They validate that video can become structured OR data, but many are broader perioperative analytics platforms rather than GI revenue-cycle products.
• GI video AI detection vendors. Detection tools prove GI clinicians will adopt AI on live procedure video, but polyp-detection products do not solve operative-note completeness, coding support, or payer defense.
• Internal dictation plus coders. The default substitute remains familiar and flexible, but it preserves memory-based documentation, rework loops, and inconsistent evidence for appeals.

Endoscopy Claim-Proof OS should start as a same-day documentation and coding evidence layer for PE-backed U.S. GI and ambulatory surgery platforms that already capture procedure video and centralize revenue-cycle operations. The urgent pain is not generic clinical documentation; it is memory-based procedure notes, coder rework, and payer exposure in high-volume colonoscopy and EGD workflows where the best evidence already exists on video but is not converted into a signed, claim-ready record fast enough. The MVP should ingest endoscopy video, room metadata, and existing note templates to produce a surgeon-reviewed procedure note plus a timestamped CPT evidence packet before the case leaves the same-day workflow. This beachhead is narrower and faster to prove than a broad surgical-AI platform because GI centers run repetitive workflows, already buy documentation software, and feel denial, throughput, and standardization pain at the platform level. The first GTM motion should sell to a VP Revenue Cycle or CFO at a 30-60 room GI platform immediately after a denial spike, coder staffing squeeze, or post-acquisition standardization push. Research supports a plausible "$425.9M" TAM, "$69.1M" beachhead SAM, and "$10.4M" modeled year-3 SOM, but those figures depend on case-based value capture and do not prove current budget line items. The biggest disconfirming risks are that too few target rooms retain usable video and metadata for production-grade note generation, or that surgeon edit rates stay high enough to make the workflow feel like extra admin. The first 12 months therefore need to prove three things in one account: reliable capture coverage, low-edit same-day note generation, and measurable reduction in coder queries or appeal-prep effort.

Problem

• Surgeons and coders still reconstruct high-volume endoscopy cases from memory, templates, and ad hoc clip lookup, which creates late addenda, coding disputes, and weak evidence in payer appeals.
• Multi-site GI platforms cannot standardize note quality and claim support across acquired centers if procedure video remains an archive asset instead of the source record for what happened in the room.

Solution

• Turn colonoscopy and EGD video plus room metadata into a surgeon-reviewed note immediately after the case, with detected procedural steps and missing-documentation prompts surfaced before sign-off.
• Attach each claim-relevant statement to timestamped visual evidence so centralized coders and appeal teams review one claim-proof packet instead of reconstructing the case from text alone.

Why we win

• The wedge is narrower than generic ambient AI and more workflow-specific than broad surgical-intelligence platforms: GI same-day documentation with reimbursement-defensible evidence.
• Incumbent GI reporting suites already own note templates and image capture, but they generally begin with manual entry rather than automated video-to-evidence synthesis.
• A data moat can compound from GI-specific procedure ontologies, surgeon edit histories, and coder or appeal outcomes that show which evidence packets actually survive review.

Milestones

flowchart LR
  Wedge[GI same-day claim-proof wedge] --> MVP[Video-linked note and evidence MVP]
  MVP --> Proof[Same-day signed notes and lower coder rework]
  Proof --> Expansion[Platform rollout and audit-defense analytics]

Founding team

Experiment roadmap

Risk assessment

What must be true

• At least 3 of the first 10 qualified GI platforms will pay for a pilot before requiring a full rip-and-replace documentation system.
• At least 70% of pilot-room cases will have enough video and metadata fidelity to generate a usable first draft.
• Median surgeon review time will drop enough that same-day sign-off is materially faster than the current process.
• Timestamped evidence packets will reduce coder queries, amendments, or appeal-prep effort by a level the economic buyer accepts as budget-justifying.
• Incumbent reporting vendors will not close the evidence-linkage gap fast enough to block the first 5 enterprise wins.

Open diligence questions

• What percentage of target GI ASC rooms already store full-fidelity procedure video with metadata that can be accessed in production?
• Which incumbent stack combinations dominate the 30-60 room GI platform segment, and where can the product write back or attach evidence today?
• What edit-rate threshold do GI physicians consider acceptable before the draft feels like extra documentation work?
• Which ROI proof converts fastest in live deals: same-day note turnaround, coder productivity, reduced downcoding, or faster appeal defense?
• How often do GI platform buyers prefer to extend Provation, EndoSoft, or Epic workflows rather than buy a separate claim-proof layer?

Model sanity

• Revenue engine. Base-case revenue is driven by 4 GI platforms by Q4Y3, with same-account room expansion contributing more than new-logo growth after Y2.
• Must go right. Pilot accounts have to convert into broader room rollouts quickly enough that usage revenue outruns the added solutions, security, and compliance cost.
• Model breaks if. The downside case appears if capture audits fail or sales cycles stretch, because that combination pushes Y3 EBITDA negative and drops cash toward the roughly $420K low point.
• Next-round proof. The next round is justified once 2 pilots convert, 4 platforms are live, and audit-defense ROI is visible on coder-query or appeal-prep metrics.

Scenarios

Sensitivity

flowchart LR
  Leads[Workflow assessments] --> Pilots[Paid pilots]
  Pilots --> Platforms[Live GI platforms]
  Platforms --> Revenue[Room + case revenue]
  Revenue --> GrossProfit[Gross profit]
  GrossProfit --> Cash[Ending cash]

Flags: Revenue concentration remains high because only 4 GI platforms account for the full base-case year-3 revenue. · The model assumes most year-3 growth comes from room expansion inside existing accounts; if operators stall at pilot-room coverage, revenue misses even without logo churn. · Year-3 revenue per FTE sits slightly above a generic SaaS benchmark even though implementation is still workflow- and compliance-heavy, so execution discipline must stay unusually strong.

• Surgeon review friction. If clinicians must heavily edit the draft, the product will feel like extra admin rather than same-day acceleration. Mitigation: Start with repetitive endoscopy workflows, measure edit-rate by template and physician, and deliver the draft inside the existing sign-off queue.
• Video integration gaps. Some centers may have inconsistent video capture, missing metadata, or fragmented reporting systems that weaken output quality. Mitigation: Launch first with operators that already record procedures reliably, support manual metadata fallback, and prioritize the most common scope and reporting vendors.
• Audit-grade trust. Revenue-cycle leaders may hesitate to rely on AI-generated coding support if they cannot prove the evidence chain in payer disputes. Mitigation: Position the first product as surgeon-reviewed documentation plus evidence packet generation, keep full timestamped audit trails, and publish appeal and edit metrics from early accounts.